Published on 13 March 2023
Body text 1
- PCT/EP2016/072458: A synthetic lethal drug combination for treating renal cell carcinoma
- PCT/EP2021/068575: Développement d'inhibiteurs de la protéine kinase CK2 ciblant l'interaction des sous-unités α/β
- PCT/EP2018/064129: Method for determining the invasive potential of a tumor cell
Top page